NOVEMBER 15TH, 2022 CONN HASTINGS MEDICINE, NANOMEDICINE, ONCOLOGY Researchers at The University of Texas MD Anderson Cancer Center have developed a nanotechnology platform that can make cancer cells more vulnerable to immune attack in the body. The researchers call their system the bispecific tumor-transforming nanoconjugate (BiTN) platform. The idea is to make solid tumors more appealing...
